NervGen Cost Of Revenue from 2010 to 2024

NGEN Stock  CAD 2.90  0.10  3.33%   
NervGen Pharma Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue is likely to outpace its year average in 2024. During the period from 2010 to 2024, NervGen Pharma Cost Of Revenue regression line of quarterly data had mean square error of 752 M and geometric mean of  49,180. View All Fundamentals
 
Cost Of Revenue  
First Reported
2010-12-31
Previous Quarter
132.4 K
Current Value
139 K
Quarterly Volatility
37.6 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NervGen Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NervGen Pharma's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 4.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NervGen financial statements analysis is a perfect complement when working with NervGen Pharma Valuation or Volatility modules.
  
This module can also supplement various NervGen Pharma Technical models . Check out the analysis of NervGen Pharma Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for NervGen Stock Analysis

When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.